Indivior

About Indivior

Indivior is a global leader in the field of addiction treatment, dedicated to helping individuals overcome substance use disorders. Founded with a mission to transform the lives of those affected by addiction, the company focuses on developing innovative therapies that address the complex challenges of addiction recovery.

With a strong commitment to research and development, Indivior invests significantly in creating evidence-based solutions that are both effective and accessible. The company’s flagship product, Suboxone, has been instrumental in treating opioid dependence, providing patients with a pathway to recovery.

Indivior operates in over 30 countries, ensuring that its products reach those in need worldwide. The company collaborates with healthcare professionals, policymakers, and community organizations to raise awareness about addiction and promote best practices in treatment.

In addition to its pharmaceutical offerings, Indivior is actively involved in educational initiatives aimed at reducing stigma associated with addiction. The company believes that informed communities are essential for fostering supportive environments for recovery.

Indivior’s vision is to be the most trusted partner in addiction treatment, continuously striving to improve patient outcomes through innovation and collaboration. The company is guided by its core values of integrity, compassion, and excellence, which underpin all its operations.

As part of its commitment to corporate social responsibility, Indivior engages in various programs that support mental health and well-being, recognizing the interconnectedness of mental health and addiction.

Through its dedication to improving the lives of individuals struggling with addiction, Indivior aims to create a world where recovery is possible for everyone.